Morgan Stanley’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
|
|||||
|
2025
Q1 | $397K | Sell |
|
|||||
|
2024
Q4 | $746K | Buy |
|
|||||
|
2024
Q3 | $970K | Sell |
|
|||||
|
2024
Q2 | $1.83M | Buy |
|
|||||
|
2024
Q1 | $158K | Sell |
|
|||||
|
2023
Q4 | $619K | Buy |
|
|||||
|
2023
Q3 | $506K | Sell |
|
|||||
|
2023
Q2 | $905K | Sell |
|
|||||
|
2023
Q1 | $1.3M | Buy |
|
|||||
|
2022
Q4 | $3.71M | Sell |
|
|||||
|
2022
Q3 | $7.37M | Buy |
|
|||||
|
2022
Q2 | $8.7M | Buy |
|
|||||
|
2022
Q1 | $9.07M | Buy |
|
|||||
|
2021
Q4 | $20.3M | Buy |
|
|||||
|
2021
Q3 | $15.6M | Buy |
|
|||||
|
2021
Q2 | $8.19M | Sell |
|
|||||
|
2021
Q1 | $10.4M | Buy |
|
|||||
|
2020
Q4 | $7.88M | Buy |
|
|||||
|
2020
Q3 | $6.71M | Buy |
|
|||||
|
2020
Q2 | $8.92M | Sell |
|
|||||
|
2020
Q1 | $12.2M | Buy |
|
|||||
|
2019
Q4 | $12.5M | Buy |
|
|||||
|
2019
Q3 | $9.19M | Buy |
|
|||||
|
2019
Q2 | $16.2M | Sell |
|
|||||
|
2019
Q1 | $27.7M | Sell |
|
|||||
|
2018
Q4 | $46M | Buy |
|
|||||
|
2018
Q3 | $78.6M | Buy |
|
|||||
|
2018
Q2 | $58.7M | Sell |
|
|||||
|
2018
Q1 | $136M | Buy |
|
|||||
|
2017
Q4 | $44.8M | Buy |
|
|||||
|
2017
Q3 | $16.9M | Buy |
|
|||||
|
2017
Q2 | $12.9M | Buy |
|
|||||
|
2017
Q1 | $13.9M | Sell |
|
|||||
|
2016
Q4 | $13M | Buy |
|
|||||
|
2016
Q3 | $10.2M | Buy |
|
|||||
|
2016
Q2 | $6.83M | Sell |
|
|||||
|
2016
Q1 | $7M | Buy |
|
|||||
|
2015
Q4 | $8.18M | Sell |
|
|||||
|
2015
Q3 | $5.56M | Sell |
|
|||||
|
2015
Q2 | $6.67M | Sell |
|
|||||
|
2015
Q1 | $6.12M | Buy |
|
|||||
|
2014
Q4 | $8.56M | Sell |
|
|||||
|
2014
Q3 | $6.73M | Sell |
|
|||||
|
2014
Q2 | $8.07M | Sell |
|
|||||
|
2014
Q1 | $7.97M | Sell |
|
|||||
|
2013
Q4 | $8.72M | Buy |
|
|||||
|
2013
Q3 | $5.92M | Buy |
|
|||||
|
2013
Q2 | $5.47M | Buy |
|